다비타 헬스케어 파트너스 (DVA) 주가

다비타 헬스케어 파트너스(DVA)는 NYSE에 상장된 Healthcare · Medical Care Facilities 기업입니다. 현재가 $183.86 (+0.42%), 시가총액 $12.75B, PER (주가수익비율) 19.12, 52주 최저~최고 $103.87 ~ $200.54.

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis dialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company offers integrated care and disease management services to patients in risk-based and other integrated care arrangements; clinic

핵심 지표

• 현재가: $183.86 (+0.42%)
• 시가총액: $12.75B
• PER (주가수익비율): 19.12
• 52주 최저~최고: $103.87 ~ $200.54
• 섹터: Healthcare
• 산업: Medical Care Facilities
• 거래소: NYSE

다비타 헬스케어 파트너스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackAll Trade에서 실시간으로 확인할 수 있습니다.

다비타 헬스케어 파트너스 재무 요약

애널리스트 전망

• 투자의견 컨센서스: 3.1

핵심 재무비율 · 수익성 · 성장성

• PBR (주가순자산비율): 21.63
• 순이익률: 0.06%
• 영업이익률: 0.14%

자주 묻는 질문